Totals
- Total revenue
- $220,819,216
- Total expenses
- $207,344,800
- Contributions and grants received
- $31,822,899
- Grants paid
- $4,178,503
- Program service revenue
- $183,233,449
- Investment income
- $5,541,393
- Other revenue
- $221,475
- Total assets, end of year
- $141,863,484
- Total liabilities, end of year
- $26,736,333
- Net assets or fund balances, end of year
- $115,127,151
- Program services expenses (Part IX)
- $178,155,376
- Management and general expenses
- $29,189,424
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $178,155,376
Program services were 85.9% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1d · Related organizations
$8,273,184
-
1e · Government grants (contributions)
$21,118,751
-
1f · All other contributions, gifts and grants
$2,430,964
-
2a · Program service revenue: PHARMACY
total $54,057,206 · related or exempt $54,057,206
-
2b · Program service revenue: BLOOD SERVICES
total $51,795,488 · related or exempt $51,795,488
-
2c · Program service revenue: DIAGNOSTIC LABORATORIES
total $40,658,823 · related or exempt $40,658,823
-
2d · Program service revenue: ORGAN AND TISSUE DONATION
total $19,999,163 · related or exempt $19,999,163
-
2e · Program service revenue: MEDICAL SERVICES
total $12,039,912 · related or exempt $12,039,912
-
2f · All other program service revenue
total $4,682,857 · related or exempt $4,530,647 · excluded $152,210
-
3 · Investment income
total $1,484,098 · excluded $1,484,098
-
6a · Gross rents
real property $30,000
-
6b · Less rental expenses
real property $41,881
-
6c · Rental income or loss
real property -$11,881
-
6d · Net rental income or loss
total -$11,881 · excluded -$11,881
-
7a · Gross sales of assets other than inventory
securities $35,201,775 · other assets $60,120
-
7b · Less cost or other basis and sales expenses
securities $31,058,137 · other assets $146,463
-
7c · Gain or loss
securities $4,143,638 · other assets -$86,343
-
7d · Net gain or loss
total $4,057,295 · excluded $4,057,295
-
11a · Other revenue: SHARED SERVICE FEE
total $140,698 · unrelated business $140,698
-
11b · Other revenue: ACQUIRED CASH RECEIPTS
total $91,000 · excluded $91,000
-
11c · Other revenue: INSURANCE INTEREST
total $1,148 · related or exempt $1,148
-
11d · All other revenue
total $510 · excluded $510
-
11e · Other revenue, total
$233,356
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $4,178,503 · program services $4,178,503
-
5 · Compensation of officers, directors and key employees
total $3,476,227 · program services $1,461,518 · management and general $2,014,709
-
6 · Compensation of disqualified persons
total $146,600 · management and general $146,600
-
7 · Other salaries and wages
total $62,360,026 · program services $53,631,794 · management and general $8,728,232
-
8 · Pension plan contributions
total $3,103,124 · program services $2,653,698 · management and general $449,426
-
9 · Other employee benefits
total $9,832,424 · program services $8,323,232 · management and general $1,509,192
-
10 · Payroll taxes
total $4,640,009 · program services $3,891,118 · management and general $748,891
-
11b · Fees: legal
total $274,937 · program services $152,591 · management and general $122,346
-
11d · Fees: lobbying
total $27,698 · management and general $27,698
-
11f · Fees: investment management
total $6,009 · management and general $6,009
-
11g · Fees: other
total $23,146,671 · program services $22,058,858 · management and general $1,087,813
-
12 · Advertising and promotion
total $450,441 · program services $152,793 · management and general $297,648
-
13 · Office expenses
total $135,651 · program services $118,645 · management and general $17,006
-
14 · Information technology
total $2,178,379 · program services $1,601,494 · management and general $576,885
-
15 · Royalties
total $13,080 · program services $13,080
-
16 · Occupancy
total $4,662,204 · program services $2,758,882 · management and general $1,903,322
-
17 · Travel
total $2,060,184 · program services $1,854,618 · management and general $205,566
-
19 · Conferences, conventions and meetings
total $436,014 · program services $381,045 · management and general $54,969
-
20 · Interest
total $392 · program services $392
-
22 · Depreciation, depletion and amortization
total $4,062,108 · program services $2,457,691 · management and general $1,604,417
-
23 · Insurance
total $143,606 · program services $83,660 · management and general $59,946
-
24a · Other expenses: COST OF IMPORTED PROD
total $46,664,817 · program services $46,664,817
-
24b · Other expenses: MEDICAL LAB SUPPLIES
total $18,902,826 · program services $18,902,826
-
24c · Other expenses: VERSITI SERVICES ALLOC
total $12,616,284 · program services $3,652,881 · management and general $8,963,403
-
24d · Other expenses: EQUIPMENT LEASE/MAINT
total $2,147,109 · program services $1,675,861 · management and general $471,248
-
24e · All other expenses
total $1,679,477 · program services $1,485,379 · management and general $194,098
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $563,832 · end of year $1,225,979
-
2 · Savings and temporary cash investments
beginning of year $0 · end of year $0
-
3 · Pledges and grants receivable
beginning of year $2,901,523 · end of year $3,463,590
-
4 · Accounts receivable
beginning of year $30,228,519 · end of year $35,985,416
-
5 · Loans and receivables from officers and key people
beginning of year $0 · end of year $0
-
6 · Loans and receivables from disqualified persons
beginning of year $0 · end of year $0
-
7 · Other notes and loans receivable
beginning of year $0 · end of year $0
-
8 · Inventories for sale or use
beginning of year $8,059,655 · end of year $9,531,534
-
9 · Prepaid expenses and deferred charges
beginning of year $718,454 · end of year $586,811
-
10a · Land, buildings and equipment: cost or other basis
$111,520,895
-
10b · Land, buildings and equipment: accumulated depreciation
$80,420,844
-
10c · Land, buildings and equipment, net
beginning of year $31,861,842 · end of year $31,100,051
-
11 · Investments: publicly traded securities
beginning of year $46,206,579 · end of year $40,113,083
-
12 · Investments: other securities
beginning of year $17,373,710 · end of year $17,881,849
-
13 · Investments: program-related
beginning of year $0 · end of year $0
-
14 · Intangible assets
beginning of year $733,790 · end of year $939,531
-
15 · Other assets
beginning of year $56,258 · end of year $1,035,640
-
17 · Accounts payable and accrued expenses
beginning of year $20,617,119 · end of year $18,514,949
-
18 · Grants payable
beginning of year $0 · end of year $0
-
19 · Deferred revenue
beginning of year $385,588 · end of year $329,670
-
20 · Tax-exempt bond liabilities
beginning of year $0 · end of year $0
-
21 · Escrow or custodial account liability
beginning of year $0 · end of year $0
-
22 · Loans and payables to officers and key people
beginning of year $0 · end of year $0
-
23 · Secured mortgages and notes payable
beginning of year $0 · end of year $0
-
24 · Unsecured notes and loans payable
beginning of year $0 · end of year $0
-
25 · Other liabilities
beginning of year $8,707,099 · end of year $7,891,714
-
27 · Net assets without donor restrictions
beginning of year $108,994,356 · end of year $115,127,151
Mission and programs · 2022
Mission
VERSITI WISCONSIN, INC. (VERSITI) IS A BLOOD HEALTH INNOVATOR WHO ENHANCES LIVES THROUGH DISCOVERY, DIAGNOSIS AND TREATMENT. VERSITI EXPANDS THE FRONTIERS OF PATIENT HEALTH THROUGH THE INTEGRATION OF SCIENCE, MEDICINE AND SERVICE.
Activities or mission (Part I)
(SEE SCHEDULE O) VERSITI WISCONSIN, INC. (VERSITI WISCONSIN) IS A BLOOD HEALTH INNOVATOR WHO ENHANCES LIVES THROUGH DISCOVERY, DIAGNOSIS AND TREATMENT. VERSITI EXPANDS THE FRONTIERS OF PATIENT HEALTH THROUGH THE INTEGRATION OF SCIENCE, MEDICINE AND SERVICE.
-
VERSITI OPERATES THE COMPREHENSIVE CENTER FOR BLEEDING DISORDERS (CCBD), UNDER A FEDERAL SUBAWARD AGREEMENT OF THE SOCIAL SECURITY ACT. CCBD PROVIDES CRITICAL SERVICES TO BLEEDING AND CLOTTING DISORDER PATIENTS AND THEIR FAMILIES. AS A COVERED ENTITY UNDER THE FEDERAL 340B DRUG DISCOUNT PROGRAM, VERSITI IS ELIGIBLE TO ACCESS CERTAIN SPECIALTY PHARMACEUTICALS AT DISCOUNTED PRICING. PHARMACEUTICAL NET INCOME IS PROGRAM INCOME AND FUNDS ARE RESTRICTED TO ACTIVITIES AND EXPENDITURES THAT FURTHER ELIGIBLE PROJECTS AND PROGRAM OBJECTIVES; INCLUDING PATIENT CARE, EDUCATION, SUPPORT SERVICES, APPROVED GRANT RESEARCH AND OTHER COSTS. VERSITI PROVIDES THESE SPECIALTY PHARMACY PRODUCTS TO HOME CARE PATIENTS AND HOSPITAL SYSTEMS. DURING 2022, 17,695 VIALS OF SPECIALTY PHARMACY PRODUCTS WERE PROVIDED.
Expenses $47,039,347 · Grants $114,000 · Revenue $54,057,206
-
VERSITI RECRUITS VOLUNTEER BLOOD DONORS, COLLECTS, PROCESSES AND DISTRIBUTES BLOOD AND BLOOD COMPONENTS TO PROVIDE A SAFE AND RELIABLE SUPPLY OF BLOOD FOR HOSPITALS AND OTHER BLOOD CENTERS SERVED. DURING 2022, 153,460 BLOOD UNITS WERE COLLECTED.
Expenses $41,230,588 · Grants $46,935 · Revenue $51,796,636
-
VERSITI RESEARCH ADVANCES THE SCIENTIFIC AND MEDICAL UNDERSTANDING OF BLOOD BIOLOGY AND BLOOD DISEASE TO IMPROVE HEALTH. DURING 2022, VERSITI HAD 40 INVESTIGATORS.
Expenses $33,192,452 · Grants $4,010,500
-
A. VERSITI WISCONSIN, INC. (VERSITI) PROVIDES CLINICAL DIAGNOSTIC TESTING SERVICES TO HOSPITALS, PHYSICIAN OFFICES AND OTHER REFERENCE LABORATORIES. DURING 2022, 130,638 TESTS WERE PERFORMED.B. VERSITI ORGAN AND TISSUE DONATION COMBINES PROCUREMENT SERVICES AND EDUCATION TO ENHANCE THE LIVES OF PATIENTS AND PROVIDES GUIDANCE TO THE FAMILIES OF POTENTIAL DONORS. DURING 2022, 380 ORGANS WERE TRANSPLANTED AND 526 MUSKULOSKELETAL DONORS WERE SEEN.C. VERSITI MEDICAL SERVICES PROVIDES MEDICAL AND THERAPEUTIC SERVICES IN PARTNERSHIP WITH LOCAL HOSPITALS. DURING 2022, 3,668 THERAPEUTIC PROCEDURES WERE PERFORMED.D. VERSITI DONOR TESTING LABORATORY PROVIDES INFECTIOUS DISEASE TESTING TO DETERMINE DONOR SUITABILITY AND PRODUCT SAFETY FOR VERSITI AFFILIATES AND OTHER BLOOD CENTER PARTNERS.THE COMBINED TOTALS FOR DIAGNOSTIC LABORATORY, ORGAN AND TISSUE DONATION, MEDICAL SERVICES, AND DONOR TESTING LABORATORY ARE SUMMARIZED BELOW.
Expenses $56,692,989 · Grants $7,068 · Revenue $77,380,755
As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Chris MiskelCHRIS MISKEL
PRESIDENT & CEO
- Total calculated
- $1,401,640
- From this org
- $567,313
- From related orgs
- $783,433
- Other
- $50,894
- Hours/week
- 21 + 34 related
Schedule J breakdown matched by us
- Base
- $312,928 + $432,138 related
- Bonus
- $245,284 + $338,726 related
- Other
- $9,101 + $12,569 related
- Deferred
- $8,610 + $11,890 related
- Nontaxable benefits
- $12,767 + $17,627 related
- Filer's total
- $588,690 + $812,950 related
-
Brian BautistaBRIAN BAUTISTA
EVP & CHIEF OPERATING OFFICER
- Total calculated
- $759,440
- From this org
- $297,280
- From related orgs
- $410,530
- Other
- $51,630
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $187,049 + $258,306 related
- Bonus
- $101,298 + $139,887 related
- Other
- $8,933 + $12,337 related
- Deferred
- $8,302 + $11,466 related
- Nontaxable benefits
- $13,382 + $18,480 related
- Filer's total
- $318,964 + $440,476 related
-
Bart ReuterBART REUTER
EVP & GENERAL COUNSEL
- Total calculated
- $714,657
- From this org
- $274,726
- From related orgs
- $379,387
- Other
- $60,544
- Hours/week
- 21 + 34 related
Schedule J breakdown matched by us
- Base
- $163,903 + $226,345 related
- Bonus
- $101,365 + $139,980 related
- Other
- $9,458 + $13,062 related
- Deferred
- $8,967 + $12,383 related
- Nontaxable benefits
- $16,463 + $22,731 related
- Filer's total
- $300,156 + $414,501 related
-
Gitesh DubalGITESH DUBAL
EVP & CHIEF MARKETING OFFICER
- Total calculated
- $649,066
- From this org
- $250,616
- From related orgs
- $346,087
- Other
- $52,363
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $151,042 + $208,580 related
- Bonus
- $90,469 + $124,932 related
- Other
- $9,105 + $12,575 related
- Deferred
- $8,610 + $11,890 related
- Nontaxable benefits
- $13,383 + $18,480 related
- Filer's total
- $272,609 + $376,457 related
-
Anthony WatkinsANTHONY WATKINS
EVP & CHIEF FINANCIAL OFFICER
- Total calculated
- $646,646
- From this org
- $247,116
- From related orgs
- $341,253
- Other
- $58,277
- Hours/week
- 16 + 28 related
Schedule J breakdown matched by us
- Base
- $153,673 + $212,214 related
- Bonus
- $83,094 + $114,748 related
- Other
- $10,349 + $14,291 related
- Deferred
- $8,967 + $12,383 related
- Nontaxable benefits
- $15,510 + $21,417 related
- Filer's total
- $271,593 + $375,053 related
-
Michael Deininger MDMICHAEL DEININGER MD
EVP & CHIEF SCIENTIFIC OFFICER
- Total calculated
- $626,680
- From this org
- $530,569
- From related orgs
- $58,951
- Other
- $37,160
- Hours/week
- 48 + 7 related
Schedule J breakdown matched by us
- Base
- $445,591 + $49,510 related
- Bonus
- $30,177 + $3,353 related
- Other
- $54,801 + $6,088 related
- Deferred
- $14,454 + $1,606 related
- Nontaxable benefits
- $18,990 + $2,110 related
- Filer's total
- $564,013 + $62,667 related
-
Bradley PietzBRADLEY PIETZ
EVP & CHIEF LABORATORY OFFICER
- Total calculated
- $538,506
- From this org
- $201,772
- From related orgs
- $278,637
- Other
- $58,097
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $116,609 + $161,031 related
- Bonus
- $75,466 + $104,214 related
- Other
- $9,697 + $13,392 related
- Deferred
- $8,742 + $12,072 related
- Nontaxable benefits
- $15,658 + $21,625 related
- Filer's total
- $226,172 + $312,334 related
-
James WeidnerJAMES WEIDNER
EVP & CHIEF HR OFFICER
- Total calculated
- $520,352
- From this org
- $197,254
- From related orgs
- $272,400
- Other
- $50,698
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $125,651 + $173,519 related
- Bonus
- $61,003 + $84,242 related
- Other
- $10,600 + $14,639 related
- Deferred
- $8,967 + $12,383 related
- Nontaxable benefits
- $12,326 + $17,022 related
- Filer's total
- $218,547 + $301,805 related
-
Peter Newman PhDPETER NEWMAN PHD
VP RESEARCH & ASSOC DIR BRI
- Total calculated
- $509,032
- From this org
- $473,785
- From related orgs
- $0
- Other
- $35,247
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $365,971
- Bonus
- $80,380
- Other
- $27,434
- Deferred
- $24,400
- Nontaxable benefits
- $10,847
- Filer's total
- $509,032
-
Lynne BriggsLYNNE BRIGGS
VP & CHIEF INFORMATION OFFICER
- Total calculated
- $487,347
- From this org
- $180,005
- From related orgs
- $248,581
- Other
- $58,761
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $126,521 + $174,721 related
- Bonus
- $51,161 + $70,652 related
- Other
- $2,323 + $3,208 related
- Deferred
- $10,248 + $14,152 related
- Nontaxable benefits
- $14,432 + $19,929 related
- Filer's total
- $204,685 + $282,662 related
-
Matthew Anderson MDMATTHEW ANDERSON MD
VP & DIAGNOSTIC LAB MED DIR
- Total calculated
- $472,235
- From this org
- $413,296
- From related orgs
- $0
- Other
- $58,939
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $349,658
- Bonus
- $60,750
- Other
- $2,888
- Deferred
- $21,350
- Nontaxable benefits
- $37,589
- Filer's total
- $472,235
-
Lynn M Malec MDLYNN M MALEC MD
SENIOR MEDICAL DIRECTOR
- Total calculated
- $431,989
- From this org
- $388,848
- From related orgs
- $0
- Other
- $43,141
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $311,334
- Bonus
- $75,810
- Other
- $1,704
- Deferred
- $11,301
- Nontaxable benefits
- $31,840
- Filer's total
- $431,989
-
Kathleen E Puca MDKATHLEEN E PUCA MD
SENIOR MEDICAL DIRECTOR
- Total calculated
- $427,328
- From this org
- $379,642
- From related orgs
- $0
- Other
- $47,686
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $331,605
- Bonus
- $18,400
- Other
- $29,637
- Deferred
- $24,400
- Nontaxable benefits
- $23,286
- Filer's total
- $427,328
-
Bob Montgomery MDBOB MONTGOMERY MD
SENIOR INVESTIGATOR
- Total calculated
- $394,506
- From this org
- $357,566
- From related orgs
- $0
- Other
- $36,940
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $314,465
- Bonus
- $18,360
- Other
- $24,741
- Deferred
- $12,593
- Nontaxable benefits
- $24,347
- Filer's total
- $394,506
-
Alexandra PieperALEXANDRA PIEPER
VP & CHIEF QUALITY OFFICER
- Total calculated
- $377,214
- From this org
- $137,522
- From related orgs
- $189,912
- Other
- $49,780
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $121,091 + $167,220 related
- Bonus
- $0
- Other
- $16,431 + $22,692 related
- Deferred
- $8,610 + $11,890 related
- Nontaxable benefits
- $12,298 + $16,982 related
- Filer's total
- $158,430 + $218,784 related
-
Margaret McElligottMARGARET MCELLIGOTT
FORMER VP & CHIEF QUALITY OFFICER
- Total calculated
- $349,051
- From this org
- $133,917
- From related orgs
- $184,935
- Other
- $30,199
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $65,313 + $90,193 related
- Bonus
- $58,330 + $80,550 related
- Other
- $10,274 + $14,192 related
- Deferred
- $6,057 + $8,366 related
- Nontaxable benefits
- $6,626 + $9,150 related
- Filer's total
- $146,600 + $202,451 related
-
Barbara BryantBARBARA BRYANT
EVP & CHIEF MED OFF - AS OF 11/2022
- Total calculated
- $199,733
- From this org
- $195,264
- From related orgs
- $0
- Other
- $4,469
- Hours/week
- 54 + 1 related
Schedule J breakdown matched by us
- Base
- $76,464
- Bonus
- $50,000
- Other
- $68,800
- Deferred
- $4,119
- Nontaxable benefits
- $350
- Filer's total
- $199,733
-
Joshua J Field MDJOSHUA J FIELD MD
SR MED DIR(INT CH MED OFF)-THRU 4/22
- Total calculated
- $152,634
- From this org
- $138,846
- From related orgs
- $0
- Other
- $13,788
- Hours/week
- 54 + 1 related
Schedule J breakdown matched by us
- Base
- $93,924
- Bonus
- $27,220
- Other
- $17,702
- Deferred
- $4,534
- Nontaxable benefits
- $9,254
- Filer's total
- $152,634
-
Thomas Hauske JrTHOMAS HAUSKE JR
CHAIR
- Total calculated
- $0
- Hours/week
- 1 + 5 related
-
Fred GeilfussFRED GEILFUSS
VICE CHAIR; LEGAL ADVISOR
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Sherry HusaSHERRY HUSA
SECRETARY
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
John PerrasJOHN PERRAS
TREASURER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Coreen Dicus-Johnson JDCOREEN DICUS-JOHNSON JD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
David Ginsburg MDDAVID GINSBURG MD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Gail HansonGAIL HANSON
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Dale KentDALE KENT
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Robert H ManegoldROBERT H MANEGOLD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 5 related
-
Jefferey S McDonaldJEFFEREY S MCDONALD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Ron MillerRON MILLER
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Kathy Thornton-BiasKATHY THORNTON-BIAS
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Greg WesleyGREG WESLEY
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
L Alan WhaleyL ALAN WHALEY
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Peter ZieglerPETER ZIEGLER
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 1a · Personal services (maid, chauffeur, chef)
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
Answered no
- 1b · Written policy on the line-1a expenses
- 2 · Substantiation required before reimbursing expenses
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- PART I, LINE 1A
- PERSONAL SERVICES VERSITI WISCONSIN PROVIDED MOVING EXPENSES FOR THE FOLLOWING EMPLOYEES: MICHAEL DEININGER, M.D. $36,441 AND BARBARA BRYANT $67,893. THE MOVING EXPENSES ARE TREATED AS TAXABLE COMPENSATION.
- PART I, LINE 3
- TOP MANAGEMENT'S COMPENSATION THE EXECUTIVE COMMITTEE OF THE VERSITI BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR VERSITI AND THE RELATED ENTITIES THAT IT SUPPORTS, INCLUDING VERSITI WISCONSIN. OTHER THAN THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER, THE EXECUTIVE COMMITTEE DOES NOT INCLUDE MEMBERS OF MANAGEMENT. TO ENSURE THAT THE COMMITTEE IS COMPRISED OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITH RESPECT TO VERSITI COMPENSATION ARRANGEMENTS, ONE MEMBER OF THE COMMITTEE RECUSES HIMSELF FROM DISCUSSIONS AND APPROVALS RELATED TO COMPENSATION; IN ADDITION, THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER RECUSES HER/HIMSELF FROM ALL DISCUSSIONS AND APPROVALS RELATED TO HER/HIS COMPENSATION. THE VERSITI EXECUTIVE COMMITTEE REVIEWS EXECUTIVE COMPENSATION ARRANGEMENTS TO ENSURE SUCH ARRANGEMENTS ARE FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO SIMILARLY-SITUATED EXECUTIVES. EXECUTIVE COMPENSATION ARRANGEMENTS ARE REVIEWED FOR REASONABLENESS AND APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY IN ACCORDANCE WITH THE VERSITI REASONABLENESS REVIEW POLICY. IN ORDER TO ASSESS THE REASONABLENESS OF EXECUTIVE COMPENSATION ARRANGEMENTS, THE EXECUTIVE COMMITTEE OBTAINS AND REVIEWS APPROPRIATE COMPARABILITY DATA COLLECTED BY THE HUMAN RESOURCE DEPARTMENT AND/OR A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT. THE EXECUTIVE COMMITTEE ENGAGES A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT ANNUALLY. THE INDEPENDENT CONSULTANT PERFORMS AN ANALYSIS OF COMPENSATION LEVELS AT REGIONAL AND NATIONAL ORGANIZATIONS OF COMPARABLE SIZE, SCOPE AND STRUCTURE; AND PROVIDES THE COMMITTEE WITH COMPREHENSIVE DATA ON THE AVAILABILITY OF SIMILAR SERVICES WITHIN THE GEOGRAPHIC AREA, COMPENSATION SURVEYS, WRITTEN OFFERS FROM SIMILAR INSTITUTIONS, AND OTHER INFORMATION RELEVANT TO COMPARABILITY OF COMPENSATION. THE EXECUTIVE COMMITTEE'S REVIEW, RECOMMENDATIONS AND APPROVALS ARE DOCUMENTED CONCURRENTLY IN THE COMMITTEE MINUTES, WHICH ARE SUBSEQUENTLY REVIEWED AND APPROVED BY THE EXECUTIVE COMMITTEE AS REASONABLE, ACCURATE AND COMPLETE. THE COMMITTEE CHAIR VERBALLY COMMUNICATES TO THE VERSITI BOARD OF DIRECTORS A CONFIRMATION OF COMPENSATION REASONABLENESS AND THE OVERALL DUE DILIGENCE PROCESS. VERSITI AND VERSITI WISCONSIN HAVE INCENTIVE PROGRAMS FOR EXECUTIVES, DIRECTORS, MANAGEMENT, INVESTIGATORS AND STAFF DESCRIBED IN DETAILED WRITTEN POLICIES APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY. EVALUATION AND COMPENSATION REVIEW -CEO - EACH YEAR, THE EXECUTIVE COMMITTEE EVALUATES THE CEO'S PERFORMANCE AGAINST ESTABLISHED OBJECTIVES, DETERMINES INCENTIVE PAYMENT AND MERIT INCREASE BASED UPON PERFORMANCE AND MARKET DATA PROVIDED BY THE THIRD PARTY COMPENSATION CONSULTANT, AND WORKS WITH THE CEO TO ESTABLISH OBJECTIVES FOR THE NEXT YEAR. -EXECUTIVES - THE BOARD OF DIRECTORS HAS DELAGATED TO THE VERSITI/VERSITI WISCONSIN CEO THE PERFORMANCE ASSESSMENT AND COMPENSATION DECISIONS FOR HIS/HER TEAM AND LEADERS ELIGIBLE FOR THE VERSITI LEADERSHIP INCENTIVE PLAN. DURING THE MAY MEETING, THE EXECUTIVE COMMITTEE REVIEWS THE INCENTIVES (SHORT AND LONG-TERM) PAYOUTS AND MERIT INCREASES ASSIGNED TO THE EXECUTIVE TEAM AS PART OF THE ANNUAL COMPENSATION REASONABILITY REVIEW CONDUCTED BY AON CONSULTANTS. THE EXECUTIVE COMMITTEE REVIEWS AND APPROVES THE SALARY INCREASES AND INCENTIVE PAYOUTS OF THE CEO BEFORE PAYMENT. EXECUTIVES ARE POSITIONED WITHIN THE APPROPRIATE SALARY RANGE BASED UPON THE: -EXECUTIVE'S KNOWLEDGE, COMPETENCIES, AND EXPERIENCE, -PERFORMANCE OF THE EXECUTIVE'S AREAS OF RESPONSIBILITY, -THE EXECUTIVE'S CONTRIBUTION TO OVERALL PERFORMANCE, -THE IMPORTANCE OF RETAINING THE EXECUTIVE, -INTERNAL EQUITY CONSIDERATIONS, -THE FINANCIAL RESOURCES AVAILABLE, AND -EXECUTIVE BASE SALARY INCREASES PROVIDED IN THE COMPETITIVE MARKET.
- PART I, LINE 5A, 5B, 6A, 6B AND 7.
- NON-FIXED PAYMENTS INCENTIVE PAYOUT OPPORTUNITIES, BASED ON PERCENTAGE OF BASE PAY RATE, ARE AVAILABLE TO CERTAIN EMPLOYEES OF THE FILING ORGANIZATION. WHILE LEVELS OF THE INCENTIVE PAYOUT OPPORTUNITY ARE FIXED AND DETERMINED PERCENTAGES OF BASE COMPENSATION, THE INCENTIVE PAYOUT IS DETERMINED, IN PART, ON THE CONSOLIDATED REVENUE AND NET EARNINGS OF OPERATING DIVISIONS. THE INCENTIVE PAYOUT IS SUBJECT TO THE REVIEW OF ACCOMPLISHMENTS/OBJECTIVES AND THE ULTIMATE DETERMINATION OF INCENTIVE COMPENSATION IS SUBJECT TO PRESIDENT/CEO AND EXECUTIVE COMMITTEE OF THE BOARD APPROVAL.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
RESEARCH
-
PATIENT FINANCIAL ASSISTANCE
-
$15,000
RESEARCH
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
VERSITI BLOOD RESEARCH INSTITUTE FNDN
501(C)(3) · SUPPORTING · WI
Directly controlled by VERSITI
-
501(C)(3) · SUPPORTING · WI
-
501(C)(3) · BLOOD · IL
Directly controlled by VERSITI
-
501(C)(3) · BLOOD · MI
Directly controlled by VERSITI
-
501(C)(3) · BLOOD · IN
Directly controlled by VERSITI
Taxable family on this return
Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.
Disregarded entities
Part I: entities that legally are the filer and file no return of their own.
-
RCRC INDEPENDENT REVIEW BOARD LLC
REVIEW BOARD · TX · income $4,137,814 · assets $3,739,620
Directly controlled by VERSITI WI
Related corporations and trusts
Part IV: related organizations taxable as a corporation or trust.
-
CENETRON DIAGNOSTICS LLC
C · LABS & TRIALS · TX · 100% owned · share of income $1,308,138 · share of assets $23,720,515 · controlled entity
Directly controlled by VERSITI WI
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 31 October 2023
- IRS schema version
- 2022v5.0
- Source object
- 202313059349301721
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.